AI TextQuick Glance (AI)Headnote
Issues: (i) Whether common shareholding rendered the assessee and the overseas entities associated enterprises and validated the reference to the Transfer Pricing Officer; (ii) Whether Chapter X can bring to tax notional income absent an independent charge under sections 4 and 5; (iii) Whether an arm's-length-price adjustment made without selecting a prescribed most appropriate method could be sustained; (iv) Whether capital research expenditure qualified for deduction under section 35(1)(iv); (v) Whether an unpaid provision for leave encashment was deductible; (vi) Whether software expenditure was capital or revenue according to the duration of its benefit; (vii) Whether expenditure on a handy camera was allowable business or research expenditure rather than impermissible freebies; (viii) Whether research and development expenditure claimed as revenue expenditure under section 37 was capital expenditure.
Issue (i): Whether common shareholding rendered the assessee and the overseas entities associated enterprises and validated the reference to the Transfer Pricing Officer.
Analysis: Section 92A(2)(b) deems enterprises to be associated enterprises where a person holds not less than 26% voting power in each enterprise. The statutory deeming rule operates for the purposes of section 92A(1), and participation in management, control or capital is consequently presumed. The common shareholder held more than the prescribed threshold in the assessee and the parent company of the overseas entities. The Assessing Officer's satisfaction for making the reference was discernible from the recorded shareholding facts; no separate speaking recording of satisfaction was required.
Conclusion: The entities were associated enterprises and the reference for determination of arm's-length price was valid, in favour of the Revenue.
Issue (ii): Whether Chapter X can bring to tax notional income absent an independent charge under sections 4 and 5.
Analysis: Chapter X supplies the machinery for computing the arm's-length value of an international transaction and does not alter either the head or nature of income. Income arising from the technology transactions remained business income chargeable under sections 4 and 5.
Conclusion: Chapter X validly applies as a computation mechanism and does not create an impermissible charge of notional income, in favour of the Revenue.
Issue (iii): Whether an arm's-length-price adjustment made without selecting a prescribed most appropriate method could be sustained.
Analysis: Section 92 requires income from an international transaction to be computed having regard to arm's-length price, while section 92C(1) requires application of a prescribed most appropriate method. The ad hoc determination did not apply such a method. The assessee had also not furnished the prescribed report or its arm's-length-price computation because it denied associated-enterprise status.
Conclusion: The arm's-length-price determination was set aside and remitted for de novo determination under Chapter X; the relief is limited to fresh adjudication, in part in favour of the assessee.
Issue (iv): Whether capital research expenditure qualified for deduction under section 35(1)(iv).
Analysis: Section 35(1)(iv) permits deduction for capital expenditure on scientific research only where the research relates to the business carried on by the assessee. The research expenditure was incurred to develop marketable technology for group concerns and facilitated their business rather than an extension of the assessee's own business.
Conclusion: Deduction under section 35(1)(iv) was not allowable, in favour of the Revenue.
Issue (v): Whether an unpaid provision for leave encashment was deductible.
Analysis: The provision remained unpaid up to the due date for filing the return. Section 43B allows the deduction only upon the prescribed payment condition being satisfied.
Conclusion: The disallowance of the unpaid leave-encashment provision was sustained, in favour of the Revenue.
Issue (vi): Whether software expenditure was capital or revenue according to the duration of its benefit.
Analysis: Software intended for use over an indeterminate or extended period confers an enduring benefit and remains capital notwithstanding that it replaces or upgrades existing software. Conversely, software having validity limited to one year does not confer an enduring benefit extending beyond that period.
Conclusion: Expenditure on long-term software was capital and its disallowance was sustained in favour of the Revenue; expenditure on one-year software was revenue and allowable in favour of the assessee.
Issue (vii): Whether expenditure on a handy camera was allowable business or research expenditure rather than impermissible freebies.
Analysis: The stated use of the handy camera for recording clinical trials and research activities was not accepted. The expenditure was treated as a prohibited freebie rather than expenditure incurred for the assessee's business or research.
Conclusion: The disallowance of the handy-camera expenditure was sustained, in favour of the Revenue.
Issue (viii): Whether research and development expenditure claimed as revenue expenditure under section 37 was capital expenditure.
Analysis: The character of research expenditure depends on its intended long-term benefit, not on whether the research ultimately results in a successful product or technology. Research undertaken to obtain enduring benefit is capital in nature. As the necessary bifurcation and supporting details were unavailable, the claim required fresh factual adjudication.
Conclusion: The deletion of the research-and-development disallowance was set aside and the issue was remitted for de novo adjudication, in favour of the Revenue to that extent.
Final Conclusion: Associated-enterprise status and the statutory conditions governing scientific-research, leave-encashment, software and research expenditure claims were upheld as applied; arm's-length-price and research-expenditure computations requiring proper factual and statutory determination must be reconsidered afresh.
Ratio Decidendi: Where the statutory deeming conditions in section 92A(2) are met, associated-enterprise status follows, and any arm's-length-price adjustment must be determined through a prescribed method under section 92C.
Transfer-pricing associated-enterprise rules require prescribed arm's-length methods, while enduring-benefit tests govern software and research expenditure.
Common shareholding of at least 26% voting power in each enterprise triggers associated-enterprise status under section 92A(2), supporting transfer-pricing scrutiny. Chapter X supplies a mechanism for computing the arm's-length value of international transactions; it does not create a separate charge of notional income, and section 92C requires a prescribed most appropriate method rather than ad hoc pricing. Capital scientific-research expenditure is deductible only when related to the taxpayer's own business, while unpaid leave encashment remains subject to the applicable payment condition. Software with an enduring benefit is capital, whereas one-year software may be revenue. Research expenditure intended to yield enduring benefit is capital even if research does not succeed.
Associated enterprises - common shareholding and step-down subsidiaries - Reference to Transfer Pricing Officer - satisfaction for reference - Arm's length price-prescribed most appropriate method - Transfer-pricing provisions-machinery for valuation - Scientific research expenditure-nexus with assessee's own business - Research and development expenditure-capital or revenue character - Software expenditure-enduring benefit and annual validity - Leave-encashment provision-deduction on payment basis Associated enterprises-common shareholding and step-down subsidiaries - Treatment of the assessee and purchasers of technology as associated enterprises where a common shareholder held the prescribed voting power in the assessee and in the parent of the purchasers - HELD THAT: - The deeming provision in section 92A(2) operates for the purposes of section 92A(1). Once a condition in section 92A(2) is fulfilled, associated-enterprise status follows mandatorily, and participation in management, control or capital under section 92A(1) is necessarily presumed. Since the common shareholder held the prescribed voting power in the assessee and in the parent whose wholly owned step-down subsidiaries were the counterparties, the statutory condition stood fulfilled. [Paras 11, 12] The assessee and the purchasers were held to be associated enterprises, and the technology-sale transactions were subject to the transfer-pricing provisions. Reference to Transfer Pricing Officer-satisfaction for reference - Validity of the reference for arm's length price determination in respect of technology sales to the associated enterprises - HELD THAT: - The Assessing Officer's recording of the relevant shareholding in the assessee and the parent company established that satisfaction regarding the associated-enterprise relationship and the need for a reference was properly reached. [Paras 15] The challenge to the reference for determination of the arm's length price was rejected. Transfer-pricing provisions-machinery for valuation - Whether transfer-pricing provisions could bring to tax notional income without an independent charging provision? - HELD THAT: - Chapter X is a machinery provision for determining the arm's length value of transactions between associated enterprises; it neither changes the nature of income nor its head of charge. The technology-sale receipts remained business income, chargeable under the ordinary charging provisions even after determination of their arm's length price. [Paras 17] The plea that the transfer-pricing adjustment sought to tax income not otherwise chargeable was rejected. Arm's length price-prescribed most appropriate method - Consequence of determining the arm's length price of technology transactions without selecting a prescribed method - HELD THAT: - Determination of the arm's length price requires adoption of a prescribed most appropriate method. However, non-adoption of such a method did not compel deletion of the adjustment, particularly when the assessee had not furnished the accountant's report or its computation of arm's length price on the premise that the counterparties were not associated enterprises. Neither the assessee's determination nor the determination made by the authorities could consequently be sustained. [Paras 21, 22, 23, 24] The arm's length price issue was remanded to the Assessing Officer and the Transfer Pricing Officer for de novo determination under Chapter X; the merits of the transfer-pricing adjustment were left unadjudicated. Scientific research expenditure-nexus with assessee's own business - Deduction for capital expenditure on pharmaceutical research undertaken for developing technology for associated enterprises and sister concerns - HELD THAT: - Capital expenditure on scientific research qualifies for deduction only where the research is related to the business carried on by the assessee itself. The concurrent factual finding was that the research was undertaken for the benefit of associated enterprises or sister concerns and resulted in marketable technology, rather than facilitating extension of the assessee's own business. [Paras 25, 29, 48, 50] Deduction under section 35(1)(iv) was held unavailable; the disallowances were sustained and the Revenue's appeals on this issue were allowed. Leave-encashment provision-deduction on payment basis - Deduction for an unpaid provision for leave encashment - HELD THAT: - The provision had not been paid by the due date for filing the return. It was therefore not allowable in accordance with section 43B. [Paras 26] The disallowance of the provision for leave encashment was sustained. Software expenditure - enduring benefit - Character of expenditure on software intended for use over several years notwithstanding subsequent upgradation - HELD THAT: - Software intended for use over years, without a determined shelf life, provides an enduring benefit and is capital in character. Replacement or upgradation of existing software does not alter the capital nature of expenditure incurred for acquiring the replacement software. [Paras 30] The software-expenditure disallowance was upheld, and the alternate claim of scientific-research deduction did not survive. Business expenditure-handy cameras claimed for clinical trials - Deduction for handy cameras claimed to have been supplied for recording clinical trials - HELD THAT: - The asserted use of handy cameras for recording clinical trials and facilitating research activities was not accepted. The equipment was found not to be suitable for the claimed medical or research purpose. [Paras 36] The disallowance of the expenditure on handy cameras was affirmed. Software expenditure-limited annual validity - Character of software expenditure where the software had validity limited to one year - HELD THAT: - Where the validity and benefit of software were confined to one year, the expenditure did not yield an enduring benefit extending to multiple years. [Paras 41, 45] The software expenditure was held revenue in character, and deletion of the disallowance was sustained. Research and development expenditure-capital or revenue character - Characterisation of research-and-development expenditure incurred for product or technology development capable of producing long-term benefit - HELD THAT: - The capital or revenue character of research expenditure depends on its intended long-term benefit and not on whether the research ultimately results in a successful product or technology. As the assessee had not furnished the required bifurcation of expenditure relating to inventions generating lease rent or royalty, factual verification remained necessary. [Paras 41, 43, 45] The issue was restored to the Assessing Officer for de novo adjudication after affording the assessee an opportunity to furnish supporting evidence. Arm's length price-product-development services to associated enterprise - Transfer-pricing adjustment for product-development services supplied to an associated enterprise - HELD THAT: - An earlier decision of the Tribunal had accepted the assessee's position on materially similar facts, and the Revenue identified no basis for departure. [Paras 45] The Revenue's challenge to deletion of the transfer-pricing adjustment was dismissed. Final Conclusion: The appeals were disposed of in accordance with these findings, with remands limited to the identified transfer-pricing and research-expenditure issues.